SCHEMBL6087522

SCHEMBL6087522

COc1ccc(C(=O)O)c(OCc2cccc(OCc3ccc4ccccc4n3)c2)c1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYSLTR1 Q9Y271 12/20 0.60
GPBAR1 Q8TDU6 2/20 0.60
ALOX5 P09917 1/20 0.60
CYSLTR2 Q9NS75 8/20 0.57
KDM4E B2RXH2 1/20 0.56
MEN1 O00255 1/20 0.56
NPC1 O15118 1/20 0.56
ALDH1A1 P00352 1/20 0.56
LMNA P02545 1/20 0.56
TP53 P04637 1/20 0.56
CYP1A2 P05177 1/20 0.56
CYP3A4 P08684 1/20 0.56
CYP2D6 P10635 1/20 0.56
MAPT P10636 1/20 0.56
CYP2C9 P11712 1/20 0.56
TSHR P16473 1/20 0.56
MAPK1 P28482 1/20 0.56
CYP2C19 P33261 1/20 0.56
THPO P40225 1/20 0.56
BLM P54132 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6088393 0.93 CYSLTR1 (0.60) CYSLTR1GPBAR1ALOX5CYSLTR2KDM4E
SCHEMBL6090654 0.91 CYSLTR1 (0.63) CYSLTR1GPBAR1ALOX5ALOX5AP
SCHEMBL6089807 0.89 CYSLTR1 (0.66) CYSLTR1GPBAR1ALOX5CYSLTR2KDM4E
SCHEMBL7717089 0.88 CYSLTR1 (0.62) CYSLTR1GPBAR1ALOX5CYSLTR2KDM4E
SCHEMBL7714576 0.87 CYSLTR1 (0.64) CYSLTR1GPBAR1ALOX5CYSLTR2KDM4E
SCHEMBL6089267 0.87 CYSLTR1 (0.62) CYSLTR1GPBAR1ALOX5CYSLTR2KDM4E
SCHEMBL6090685 0.86 CYSLTR1 (0.57) CYSLTR1GPBAR1ALOX5CYSLTR2MAPT
SCHEMBL6089691 0.85 CYSLTR1 (0.60) CYSLTR1GPBAR1ALOX5CYSLTR2KDM4E
SCHEMBL7907533 0.85 MAOB (0.62) KDM4ENPC1TP53
SCHEMBL6089926 0.85 CYSLTR1 (0.61) CYSLTR1GPBAR1ALOX5CYSLTR2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7005440-B1 Therapeutic uses of tri-aryl acid derivatives AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2006-02-28 US disclosed